SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-23-037255
Filing Date
2023-03-27
Accepted
2023-03-27 20:12:43
Documents
1
Period of Report
2022-12-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2310668-4_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2310668-4_4aseq1.xml 4/A 3418
  Complete submission text file 0001104659-23-037255.txt   4816
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Issuer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01752
Business Address
Nolan Garry Ph.D. (Reporting) CIK: 0001857405 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40344 | Film No.: 23765925